Phase IMitochondrial Peptide
Compound 61914
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061914
Risk Class
HIGH
Last Audit
Oct 4, 2108
Research Abstract
Mitochondrial Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61914 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase i with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061914 with updates logged 2108-10-04.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61914Mitochondrial Peptide Program 61914
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061914
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61914